Cytometry Part B-Clinical Cytometry

Article	Citations
Issue highlights—January 2025	37
An uncommon case of acute megakaryoblastic leukemia with DDX3X::MLLT10 fusion gene	33
	32
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring	29
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease	24
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells	20
Issue highlights—September 2023	19
Issue Information	18
	18
	16
Issue Information	16
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel	14
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients	14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma	13
Standardization of flow cytometric detection of antigen expression	13
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi	12
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia	12
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis	12
Issue Information	11
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa	11
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia	11
Issue Information	11
Issue Information	10
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes	10
ROR1 expression in mature B lymphoid neoplasms by flow cytometry	10

Issue Highlights—January 2022	10
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric	9
Issue Information	9
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia	9
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow	9
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry	8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays	8
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry	8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT	8
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR	8
	8
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International	7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia	7
Anti‐CD38 VHH antibody (JK36) reliably detects CD38 yet uncovers CD38 downregulation in a subset of daratumumab‐treated multiple myeloma patients	6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies	6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry	6
	6
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry	6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis	6
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening	5
Editorial on IVD cellular assay validation	5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry	5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience	5
	5
	5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring	5
Possible alternative strategies to implement basophil activation testing in multicentric studies	5
Issue Information	5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds	5
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation	4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup	4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD7	4
Issue Information	4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma	4
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet	4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases	4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia	4
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome	4
Issue Highlights—July 2022	4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care	4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis	4
Issue Highlights—November 2021	4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis	3
	3
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms	3
Flow cytometry in the diagnosis of myelodysplastic syndromes	3
Issue highlights—May 2023	3
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry	3
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients	3
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study	3

	3
	3
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti	3
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder	3
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia	3
The use of erythrocytes as biomarkers with a timeline	3
Issue highlights—November 2024	3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent	3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease	3
	3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern	3
Issue Information	3
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience	3
Issue Information	3
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions	3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition	3
Issue highlights—July 2024	3
Issue Highlights—July 2025	3
Issue Highlights—March 2022	3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia	3
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma	2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow	2
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes	2
Recommendations for using artificial intelligence in clinical flow cytometry	2
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp	2
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome	2
Noel Warner Ph.D.	2
Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41‐positive progenitor cells	2
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy	2
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall	2
Issue highlights—September 2024	2
Issue highlights—July 2023	2
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS	2
Issue Information	2
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia	2
The role of CD20+ T cells: Insights in human peripheral blood	2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection	2
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow	2
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients	2
	2
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry	2
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands	2
Issue Highlights—September 2022	2
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country	2
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di	1
	1
	1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry	1
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders	1
Issue Information	1
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm	1
Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia	1
	1
Comparison of monoclonal antibody to CD59 for the diagnosis of paroxysmal nocturnal hemoglobinuria by flow cytometry	1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data	1
A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases	1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies	1
Issue Information	1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia	1
Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis	1
Issue Information	1
	1
	1
Automation in flow cytometry: Guidelines and review of systems	1
Cross‐sectional reassessment after 4 years of clinical routine use of AQUIOS CL for absolute T cell quantitation in a university hospital	1
Issue Information	1
Human leukocyte antigen‐B27 typing by flow cytometry: Comparison of three CE‐IVD methods	1
Issue Highlights—September 2021	1
Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot‐plot based analysis for flow cytometry	1
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor	1
Toward immunoprofiling in MDS: A computational study of the bone marrow immune microenvironment	1
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors	1
	1
Issue highlights—November 2022	1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation	1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry	1
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry	1
Issue highlights—February 2024	1
Integrated analysis of genotype and phenotype reveals clonal evolution and cytogenetically driven disruption of myeloid cell maturation in myelodysplastic syndromes	1
Circulating CD22+/CD19−/CD24− progenitors and CD22+/CD19+/CD24− mature B cells: Diagnostic pitfalls for minimal residual disease detec	1

CD5‐negative chronic lymphocytic leukemia: Does this entity really exist?	1
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes	1
ESCCA/ISCCA survey on the use of multicolor flow cytometry in the detection of cerebrospinal fluid involvement in hematological malignancies: How close does real‐life adhere to t	1
Issue Highlights—May 2022	1
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy	1